UnitedHealth Group (UNH) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification) and isn't treated as a signal here.
Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.- Next earnings expected around Jan 10, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Sale Patrick Hugh Conway, CEO sold 1,169 shares at $390.00 ($456K).
- Trade date
- Aug 21, 2026
- Disclosed to the SEC
- Aug 25, 2026
- Type
- Sale (code S)
Read the original SEC filing ↗All UNH insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
UNH insider transactions (Form 4)
Open-market purchases and sales. 132 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 25SEC | Patrick Hugh ConwayCEO | Sell | 1,16915,328 held (−7%) | $390.00 | $456K | -14.4% | — |
| Aug 7SEC | Patrick Hugh ConwayCEO | Sell | 50016,497 held (−3%) | $410.00 | $205K | -18.6% | — |
| Apr 27SEC | Patrick Hugh ConwayCEO | Sell | 80017,805 held (−4%) | $355.00 | $284K | -6.0% | — |
Similar past setups: not applicable. UNH has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with UNH in the Research Lab
UNH has no open-market insider buys in the last 12 months. Try the tools with any setup.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
UnitedHealth Group insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 1 sold $945K of UNH stock on the open market; P/E 22.0 vs. a sector median of 25.0.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
UNH insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $661K | 2 |
| Q2 2026 | — | 0 | $284K | 1 |
Valuation, profit and volume
Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 0 UnitedHealth Group insiders reported open-market purchases totaling $0, while 1 insider reported sales totaling $945K. Among insiders with enough purchase history to measure, Scott Gottlieb (Director) has the highest Insider Score at 71. 0 of 3 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
UNH earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Oct 13, 2026 | +0.5% | None | +4.5%S&P -1.1% | +3.0% |
| Jul 16, 2026 | +0.7% | None | +1.8%S&P -1.5% | -5.7% |
| Apr 21, 2026 | +16.7% | None | +9.3%S&P +0.4% | +9.9% |
| Jan 27, 2026 | +2.2% | None | -16.4%S&P +0.4% | -0.3% |
| Oct 28, 2025 | +3.2% | None | -2.9%S&P +0.3% | -7.2% |
| Jul 29, 2025 | -7.2% | None | -5.7%S&P -0.4% | +16.5% |
| Apr 17, 2025 | +11.8% | None | -27.3%S&P -2.2% | -28.8% |
| Jan 16, 2025 | +7.4% | None | -6.2%S&P +0.8% | +2.7% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
UNH short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded UNH
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| John BoozmanSenate | Bought $1,001 - $15,000 | Apr 16, 2025 | Aug 20, 2026 | -40.6% |
| Alan ArmstrongSenate | Bought $15,001 - $50,000 | Mar 27, 2026 | Jul 21, 2026 | +30.4% |
| John BoozmanSenate | Bought $1,001 - $15,000 | Jun 4, 2026 | Jul 13, 2026 | -14.8% |
| Markwayne MullinSenate | Bought $50,001 - $100,000 | Feb 25, 2026 | Mar 10, 2026 | +19.7% |
| Katie BrittSenate | Sold $1,001 - $15,000 | Apr 30, 2025 | Jan 26, 2026 | -15.6% |
| Katie BrittSenate | Bought $1,001 - $15,000 | Apr 14, 2025 | Jan 26, 2026 | -40.9% |
| Sheldon WhitehouseSenate | Sold $15,001 - $50,000 | Sep 4, 2025 | Oct 3, 2025 | +11.1% |
| Markwayne MullinSenate | Bought $15,001 - $50,000 | Sep 24, 2025 | Oct 1, 2025 | -2.6% |
Insiders at UnitedHealth Group
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Patrick Hugh ConwayCEO | — | $945K | Sep 24, 2026 | — | — |
| Timothy John NoelCEO | — | — | Nov 13, 2026 | — | — |
| Charles D. BakerDirector | — | — | Oct 5, 2026 | — | — |
| Timothy Patrick FlynnDirector | — | — | Oct 5, 2026 | — | — |
| Paul R. GarciaDirector | — | — | Oct 5, 2026 | — | — |
| Kristen GilDirector | — | — | Oct 5, 2026 | — | — |
| Scott GottliebDirector | — | — | Oct 5, 2026 | — | 71 |
| Frederick William McNabb IIIDirector | — | — | Oct 5, 2026 | — | — |
| Rice Valerie Md MontgomeryDirector | — | — | Oct 5, 2026 | — | — |
| John H. NoseworthyDirector | — | — | Oct 5, 2026 | — | — |
| Erin McSweeneyEvp & Chief People Officer | — | — | Sep 24, 2026 | — | — |
| Wayne S. DeveydtCFO | — | — | Sep 24, 2026 | — | — |
| Stephen J. HemsleyCEO | — | — | Sep 24, 2026 | — | — |
| Christopher R. ZaettaGeneral Counsel | — | — | Sep 24, 2026 | — | — |
| Dennis Andrew StankiewiczChief Accounting Officer | — | — | Sep 24, 2026 | — | — |
| Michele J. HooperDirector | — | — | Apr 6, 2026 | — | — |
| Thomas E. RoosChief Accounting Officer | — | — | Feb 25, 2026 | — | — |
Board links: companies that share insiders with UNH
Directors and executives who filed Form 4s for UNH and another company in the last 12 months.
- FLEXFlex Erin McSweeney Evp & Chief People Officer here · Director at FLEX · latest filing Sep 24, 2026
- ILMNIllumina Scott Gottlieb Director here · Director at ILMN · latest filing Oct 5, 2026
- PACSPACS Group Patrick Hugh Conway CEO here · Director at PACS · latest filing Sep 24, 2026
- WMTWalmart Timothy Patrick Flynn Director here · Director at WMT · latest filing Oct 5, 2026
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
UNH stock: common questions
Are UnitedHealth Group insiders buying UNH stock?
No. No UnitedHealth Group insider reported an open-market purchase of UNH in the past 12 months.
Are UnitedHealth Group insiders selling UNH stock?
1 insider reported sales worth $945K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is UNH's P/E ratio?
UNH trades at about 22.0 times trailing earnings, compared with a median of 25.0 for the Health Care sector.
What is UNH's 52-week range?
Over the past year UNH has traded between $255.97 and $433.68. It last closed at $333.73 on Nov 19, 2026.